Related references
Note: Only part of the references are listed.LB-100, a novel Protein Phosphatase 2A (PP2A) inhibitor, sensitizes malignant meningioma cells to the therapeutic effects of radiation
Winson S. Ho et al.
CANCER LETTERS (2018)
The novel CXCR4 antagonist, PRX177561, reduces tumor cell proliferation and accelerates cancer stem cell differentiation in glioblastoma preclinical models
Giovanni Luca Gravina et al.
TUMOR BIOLOGY (2017)
Microtubule-targeting agents can sensitize cancer cells to ionizing radiation by an interphase-based mechanism
Daniel Markowitz et al.
ONCOTARGETS AND THERAPY (2017)
Metastatic Atypical and Anaplastic Meningioma: A Case Series and Review of the Literature
Remi A. Kessler et al.
WORLD NEUROSURGERY (2017)
A network based approach to drug repositioning identifies plausible candidates for breast cancer and prostate cancer
Hsiao-Rong Chen et al.
BMC MEDICAL GENOMICS (2016)
Repurposing Metformin as Therapy for Prostate Cancer within the STAMPEDE Trial Platform
Silke Gillessen et al.
EUROPEAN UROLOGY (2016)
Medical Management of Meningiomas: Current Status, Failed Treatments, and Promising Horizons
Michael Karsy et al.
NEUROSURGERY CLINICS OF NORTH AMERICA (2016)
Preclinical effects of CRLX101, an investigational camptothecin-containing nanoparticle drug conjugate, on treating glioblastoma multiforme via apoptosis and antiangiogenesis
Chien-Ju Lin et al.
ONCOTARGET (2016)
Mebendazole and a non-steroidal anti-inflammatory combine to reduce tumor initiation in a colon cancer preclinical model
Tara Williamson et al.
ONCOTARGET (2016)
Meningioma Genomics: Diagnostic, Prognostic, and Therapeutic Applications
Wenya Linda Bi et al.
FRONTIERS IN SURGERY (2016)
Brain Penetration and Efficacy of Different Mebendazole Polymorphs in a Mouse Brain Tumor Model
Ren-Yuan Bai et al.
CLINICAL CANCER RESEARCH (2015)
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2015)
Microtubule-targeting agents augment the toxicity of DNA-damaging agents by disrupting intracellular trafficking of DNA repair proteins
Marianne S. Poruchynsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Repurposing the Antihelmintic Mebendazole as a Hedgehog Inhibitor
Andrew R. Larsen et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Effective treatment of diverse medulloblastoma models with mebendazole and its impact on tumor angiogenesis
Ren-Yuan Bai et al.
NEURO-ONCOLOGY (2015)
Drug repositioning from bench to bedside: Tumour remission by the antihelmintic drug mebendazole in refractory metastatic colon cancer
Peter Nygren et al.
ACTA ONCOLOGICA (2014)
Global progress towards eliminating gastrointestinal helminth infections
Thomas R. McCarty et al.
CURRENT OPINION IN GASTROENTEROLOGY (2014)
Preclinical evaluation of the combination of mTOR and proteasome inhibitors with radiotherapy in malignant peripheral nerve sheath tumors
A. S. Yamashita et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Role of external beam radiotherapy in the treatment of relapsing meningioma
M. Buglione et al.
MEDICAL ONCOLOGY (2014)
Management of Atypical Cranial Meningiomas, Part 2: Predictors of Progression and the Role of Adjuvant Radiation After Subtotal Resection
Sam Q. Sun et al.
NEUROSURGERY (2014)
The Integrin Inhibitor Cilengitide Affects Meningioma Cell Motility and Invasion
Annette Wilisch-Neumann et al.
CLINICAL CANCER RESEARCH (2013)
Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancer
Peter Nygren et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
Recent developments in chemotherapy for meningiomas: a review
Alan A. Moazzam et al.
NEUROSURGICAL FOCUS (2013)
A Drug Repositioning Approach Identifies Tricyclic Antidepressants as Inhibitors of Small Cell Lung Cancer and Other Neuroendocrine Tumors
Nadine S. Jahchan et al.
CANCER DISCOVERY (2013)
Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective series
Emil Lou et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Yes-Associated Protein 1 Is Activated and Functions as an Oncogene in Meningiomas
Gilson S. Baia et al.
MOLECULAR CANCER RESEARCH (2012)
Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme
Ren-Yuan Bai et al.
NEURO-ONCOLOGY (2011)
Markers for microscopic imaging of lymphangiogenesis and angiogenesis
Peter Baluk et al.
LYMPHATIC CONTINUUM REVISITED (2008)
High-resolution, small animal radiation research platform with X-ray tomographic guidance capabilities
John Wong et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Mebendazole induces apoptosis via Bcl-2 inactivation in chemoresistant melanoma cells
Nicole Doudican et al.
MOLECULAR CANCER RESEARCH (2008)
The Neurofibromatosis 2 Tumor Suppressor Gene Product, Merlin, Regulates Human Meningioma Cell Growth by Signaling through YAP
Katherine Striedinger et al.
NEOPLASIA (2008)
An orthotopic skull base model of malignant meningioma
Gilson S. Baia et al.
BRAIN PATHOLOGY (2008)
Recurrent meningioma - Salvage therapy with long-acting somatostatin analogue
Marc C. Chamberlain et al.
NEUROLOGY (2007)
A genetic strategy to overcome the senescence of primary meningioma cell cultures
Gilson S. Baia et al.
JOURNAL OF NEURO-ONCOLOGY (2006)
Dual therapy of ovarian cancer using measles viruses expressing carcinoembryonic antigen and sodium iodide symporter
K Hasegawa et al.
CLINICAL CANCER RESEARCH (2006)
Share Paper
